Literature DB >> 2170693

Antibodies to the RNase H domain of hepatitis B virus P protein are associated with ongoing viral replication.

T Weimer1, F Schödel, M C Jung, G R Pape, A Alberti, G Fattovich, H Beljaars, P M van Eerd, H Will.   

Abstract

Antibodies against the RNase H domain of human hepatitis B virus P protein(s) are frequent markers of acute and chronic virus infection (T. Weimer, K. Weimer, Z.-X. Tu, M.-C. Jung, G. R. Pape, and H. Will, J. Immunol. 143:3750-3756, 1989). In the present study, these antibodies were determined in serial serum samples of experimentally infected chimpanzees and naturally infected human patients with acute and chronic hepatitis B virus infection. Anti-P antibodies were found in the sera of both chimpanzees and humans early in infection shortly after the immunoglobulin M anti-HBc response; they persisted in chronic carriers with ongoing viral replication but declined and disappeared at the time of virus clearance from the sera. These data demonstrate that antibodies to the RNase H domain of the hepatitis B virus P protein are early markers of infection and a signal of ongoing virus replication. Falling titers indicate the decline or end of active virus production and may therefore be a prognostic sign of virus elimination in natural infection and after antiviral therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170693      PMCID: PMC248626          DOI: 10.1128/JVI.64.11.5665-5668.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  The influence of general, volatile anesthetics on the dynamic properties of model membranes.

Authors:  A Enders
Journal:  Biochim Biophys Acta       Date:  1990-11-02

2.  Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

Authors:  F di Marzo Veronese; T D Copeland; A L DeVico; R Rahman; S Oroszlan; R C Gallo; M G Sarngadharan
Journal:  Science       Date:  1986-03-14       Impact factor: 47.728

3.  Infectious hepatitis B virus from cloned DNA of known nucleotide sequence.

Authors:  H Will; R Cattaneo; G Darai; F Deinhardt; H Schellekens; H Schaller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

4.  Antibody response in cats to feline leukemia virus reverse transcriptase under natural conditions of exposure to the virus.

Authors:  P C Jacquemin; C Saxinger; R C Gallo; W D Hardy; M Essex
Journal:  Virology       Date:  1978-12       Impact factor: 3.616

5.  Inhibition of the reverse transcriptase of bovine leukemia virus by antibody in sera from leukemic cattle and immunological characterization of the enzyme.

Authors:  K D Wuu; D C Graves; J F Ferrer
Journal:  Cancer Res       Date:  1977-05       Impact factor: 12.701

6.  Cloned HBV DNA causes hepatitis in chimpanzees.

Authors:  H Will; R Cattaneo; H G Koch; G Darai; H Schaller; H Schellekens; P M van Eerd; F Deinhardt
Journal:  Nature       Date:  1982-10-21       Impact factor: 49.962

7.  Antibody to the RNA-dependent DNA polymerase of mammalian C-type RNA tumor viruses.

Authors:  S A Aaronson; W P Parks; E M Scolnick; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1971-05       Impact factor: 11.205

8.  Sequence homology between retroviral reverse transcriptase and putative polymerases of hepatitis B virus and cauliflower mosaic virus.

Authors:  H Toh; H Hayashida; T Miyata
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

9.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.

Authors:  F Galibert; E Mandart; F Fitoussi; P Tiollais; P Charnay
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

10.  Pre-S1 antigens and antibodies early in the course of acute hepatitis B virus infection.

Authors:  M Q Klinkert; L Theilmann; E Pfaff; H Schaller
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

View more
  5 in total

1.  The majority of duck hepatitis B virus reverse transcriptase in cells is nonencapsidated and is bound to a cytoplasmic structure.

Authors:  E Yao; Y Gong; N Chen; J E Tavis
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Properties of monoclonal antibodies directed against hepatitis B virus polymerase protein.

Authors:  J zu Putlitz; R E Lanford; R I Carlson; L Notvall; S M de la Monte; J R Wands
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 3.  Hepatitis B virus immunopathology.

Authors:  F V Chisari; C Ferrari
Journal:  Springer Semin Immunopathol       Date:  1995

Review 4.  Spacer Domain in Hepatitis B Virus Polymerase: Plugging a Hole or Performing a Role?

Authors:  Caitlin Pley; José Lourenço; Anna L McNaughton; Philippa C Matthews
Journal:  J Virol       Date:  2022-04-12       Impact factor: 6.549

5.  Detection of antibodies against DNA polymerase of hepatitis B virus in HBsAg-positive sera using ELISA.

Authors:  L X Rui; Y M Park; J Y Choi; B S Kim; G Jung
Journal:  Korean J Intern Med       Date:  1998-07       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.